The EFPIA highlights the risks of disrupting UK–EU medicine supply chains.

The FDA has approved a pill with the ability to track patient compliance.

Researchers find significant variation in regulation of pharmaceutical market systems in the developing world

Individual plants can be viewed as living, single-use bioreactors that can be grown from seeds...

How harmonization and international standards bodies bind trade and regulation in the pharma industry

In certain areas, there is significant disharmony across the ICH regions…

The solution to multiple drugs co-existing in a syringe may lie with microparticles

The industry requires reassurance on elemental impurities. How can media suppliers provide confidence in this area?

To ensure that cell therapy manufacture runs smoothly, the industry must embrace automation.

Respiratory drug development lags behind other therapeutic areas, but why?